Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
- Conditions
- Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
- Interventions
- Registration Number
- NCT00056459
- Lead Sponsor
- Novartis
- Brief Summary
To compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and are seeking first chemotherapy treatment
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1168
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 2 Vatalanib Oxaliplatin/5-FU/LV and placebo 1 Vatalanib Oxaliplatin/5-FU/LV and PTK787/ZK 222584
- Primary Outcome Measures
Name Time Method Progression free survival Throughout duration of study
- Secondary Outcome Measures
Name Time Method Time to progression Throughout duration of study Time to treatment failure Throughout duration of study Tolerability and safety profile Throughout duration of study Best overall response rate Throughout duration of study
Trial Locations
- Locations (144)
Alabama Hematology/Oncology
🇺🇸Birmingham, Alabama, United States
Palo Verde Hematology & Oncology
🇺🇸Glendale, Arizona, United States
Arizona Cancer Center
🇺🇸Tucson, Arizona, United States
Northeast Arkansas Clinic
🇺🇸Jonesboro, Arkansas, United States
Highlands Oncology Group
🇺🇸Springdale, Arkansas, United States
Comprehensive Blood and Cancer Center
🇺🇸Bakersfield, California, United States
Providence St. Joseph Medical Center
🇺🇸Burbank, California, United States
Compassionate Cancer Care Medical Group, Inc
🇺🇸Fountain Valley, California, United States
California Oncology of the Central Valley
🇺🇸Fresno, California, United States
Virginia K. Crosson Cancer Center
🇺🇸Fullerton, California, United States
Scroll for more (134 remaining)Alabama Hematology/Oncology🇺🇸Birmingham, Alabama, United States